Pancreatic Cancer Research

ResearcherUniversità Cattolica del Sacro CuoreNo recent work listed

Gian Carlo Mattiucci

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6500-0413; OpenAlex author ID A5056652700. Sources: OpenAlex.

Their work

Papers
19 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: none · 2019: 4 papers · 2020: 3 papers · 2021: 3 papers · 2022: 2 papers · 2023: 1 paper

Papers 19

  1. Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PA… Co-author DOI 10.3390/curroncol30060427↗
  2. Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis. Co-author DOI 10.1159/000525945↗
  3. The impact of radiomics in diagnosis and staging of pancreatic cancer. Co-author DOI 10.1177/26317745221081596↗
  4. Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients. Co-author DOI 10.1007/s00432-020-03411-7↗
  5. Correction to: Hypofractionated sequential radiotherapy boost: a promising strategy in inoperable locally advanced pancreatic cancer patients. Co-author DOI 10.1007/s00432-020-03439-9↗
  6. Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy. Co-author DOI 10.3390/diagnostics11010072↗
  7. Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1). Co-author DOI 10.1002/cam4.3330↗
  8. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. Co-author DOI 10.1016/j.tipsro.2020.06.001↗
  9. Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical … Co-author DOI 10.3390/cancers12071729↗
  10. Prognostic Impact of Presurgical CA19-9 Level in Pancreatic Adenocarcinoma: A Pooled Analysis. Co-author DOI 10.1016/j.tranon.2018.08.017↗
  11. Magnetic resonance imaging (MRI) compared with computed tomography (CT) for interobserver agreement of gross tumor volume delineation in pancreatic cancer: a m… Co-author DOI 10.1080/0284186x.2018.1546899↗
  12. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival. Last author DOI 10.1186/s12885-019-5790-2↗
  13. Online adaptive magnetic resonance guided radiotherapy for pancreatic cancer: state of the art, pearls and pitfalls. Co-author DOI 10.1186/s13014-019-1275-3↗
  14. RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer. Co-author DOI 10.21873/invivo.11136↗
  15. Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey. Co-author DOI 10.3892/or.2015.3955↗
  16. Adjuvant Chemoradiation in Pancreatic Cancer: A Pooled Analysis in Elderly (≥75 years) Patients. Co-author PMID 26026108↗
  17. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2014.07.024↗
  18. Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience. Co-author DOI 10.1186/1748-717x-9-198↗
  19. Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma. Co-author DOI 10.1245/s10434-012-2767-7↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vincenzo Valentini · 15 shared papers, 2013–2022 · strength 1.28
  2. Francesco Cellini · 12 shared papers, 2019–2023 · strength 1.24
  3. Alessio Giuseppe Morganti · 14 shared papers, 2013–2023 · strength 1.06
  4. Gabriella Macchia · 11 shared papers, 2013–2023 · strength 0.89
  5. Luca Boldrini · 6 shared papers, 2019–2022 · strength 0.71
  6. Milly Buwenge · 7 shared papers, 2019–2023 · strength 0.69
  7. Davide Cusumano · 4 shared papers, 2019–2022 · strength 0.47
  8. Alessandra Arcelli · 5 shared papers, 2019–2023 · strength 0.45
  9. Nicola Simoni · 4 shared papers, 2019–2023 · strength 0.38
  10. Sergio Alfieri · 6 shared papers, 2013–2022 · strength 0.37
  11. Renzo Mazzarotto · 3 shared papers, 2020–2023 · strength 0.31
  12. Savino Cilla · 3 shared papers, 2019–2023 · strength 0.28
  13. Mariacristina Di Marco · 3 shared papers, 2019–2023 · strength 0.28
  14. Domenico Genovesi · 5 shared papers, 2014–2020 · strength 0.28
  15. Michele Fiore · 3 shared papers, 2015–2023 · strength 0.25
  16. Luciana Caravatta · 4 shared papers, 2014–2020 · strength 0.24
  17. Maria Antonietta Gambacorta · 2 shared papers, 2021–2022 · strength 0.24
  18. Calogero Casà · 2 shared papers, 2021–2022 · strength 0.24
  19. Lorenzo Placidi · 2 shared papers, 2020–2021 · strength 0.23
  20. William F. Regine · 4 shared papers, 2014–2019 · strength 0.21
  21. Felipe Ángel Calvo · 4 shared papers, 2014–2019 · strength 0.21
  22. Robert Clell Miller · 4 shared papers, 2014–2019 · strength 0.21
  23. Joseph M. Herman · 4 shared papers, 2014–2019 · strength 0.21
  24. Massimo Falconi · 4 shared papers, 2014–2019 · strength 0.21
  25. Michele Reni · 4 shared papers, 2014–2019 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.